Back
ESC Premium Access

Galectin 3 is markedly elevated in severe heart failure and predicts improvement in LV volumes post cardiac resynchronisation therapy

Session: Prognostication in heart failure
Topic: Heart failure, other
Speaker: Miss S. Chua (Adelaide, South Australia, AU)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Miss Su Jen Chua

Adelaide, South Australia (Australia)
0 follower

6 more presentations in this session

Predicting sudden death and pump failure death in patients with heart failure and reduced ejection fraction: competing risk regression analyses of the PARADIGM-HF trial

Speaker: Doctor L. Shen (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Low serum potassium is associated with worse outcomes: Insights from the PARADIGM-HF trial

Speaker: Doctor U. Mogensen (Roskilde, DK)

Access
Abstract
Like
Thumbnail

Impact of combined atrial fibrillation and heart failure on mortality: 14-year naturalistic follow-up study

Speaker: Doctor O. Ziff (Birmingham, GB)

Access
Abstract
Slides
Like
Thumbnail

Predictors of 30-day mortality in patients with acute heart failure at emergency department admission: derivation and validation of the MEESSI-AHF scale

Speaker: Doctor O. Miro (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

The impact of T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure

Speaker: Mr P. Sulzgruber (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Prognostication in heart failure

Speakers: Miss S. Chua, Doctor L. Shen, Doctor U. Mogensen, Doctor O. Ziff, Doctor O. Miro...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources